Thromboembolism clinical trials

Explore recruiting thromboembolism clinical trials.

Recruiting thromboembolism studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Thromboembolism trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Master Protocol for a Phase 2 Randomized, Double-blind, Placebo-controlled Study of REGN9933 and REGN7508, Monoclonal Antibodies against Factor XI for Prevention of Venous Thromboembolism in Patients with a Peripherally Inserted Central Catheter (ROXI-CATH).

Spain, Romania, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

Prophylaxis of venous thromboembolic disease with LMWH (TINzaparin) in patients with metastatic colorectal cancer who start the first line of treatment.

Spain, Portugal

Therapeutic confirmatory (Phase III) EU CTIS Study details

DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCemenT: a national, multicenter, randomized, multi-arm, open-label trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Randomised, crossover bioequivalence clinical trial of apixaban 5 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions

Spain

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Comparison of the effects of prophylactic administration of Apixaban on thrombin generation in patients with de novo multiple myeloma and patients undergoing a surgery for total knee replacement: the ProApix Study

France

Therapeutic use (Phase IV) EU CTIS Study details

Low INR to Minimize bleeding with mechanical valves Trial (LIMIT)

Spain, Belgium, Denmark, Germany, Italy, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Thromboembolism trials by city

Thromboembolism in Toronto Thromboembolism in Vancouver Thromboembolism in Montreal Thromboembolism in Calgary Thromboembolism in Edmonton Thromboembolism in Ottawa Thromboembolism in Winnipeg Thromboembolism in Quebec City Thromboembolism in Hamilton Thromboembolism in Kitchener Thromboembolism in London Thromboembolism in Halifax Thromboembolism in New York Thromboembolism in Los Angeles Thromboembolism in Chicago Thromboembolism in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease